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[14]. These occult lacerations also result in AI 
symptoms. Caesarean delivery does not 
provide complete protection, because AI 
symptoms can occur after planned Caesarean 
delivery without accompanying labour [15]. 
Some symptoms might be due to pregnancy 
itself; 8–42% of women have mild AI 
symptoms before their first vaginal delivery 
during pregnancy [13,16]. Risk factors for AI 
in women over reproductive age include 
increasing age, medical comorbidities, poor 
health, UI and bowel-related symptoms. 
Table 1 provides a comprehensive list of 





The anorectal canal is surrounded by a 
complex tube of muscle fibres composed of 
the internal and external sphincters. The 
striated muscles of the external sphincter 
are under voluntary control, and are 
responsible for the squeeze tone of the 
rectal canal. The smooth muscle of the 
internal sphincter maintains resting tone. 
Both muscle groups overlap for 2 cm and 
extend up the canal for 4 cm. The external 
sphincter is attached to the perineal body 
and is surrounded by the puborectalis 
muscle. The external anal sphincter has 
three distinct muscle groups; the 
subcutaneous external anal sphincter, 
the main external anal sphincter, and the 
winged external anal sphincter. These 
divisions were recently described from MRI 
of 50 nulliparous women, in most of whom 
all three divisions could be identified. The 
exact functional role of all parts of the 
external anal sphincter remains to be 
described [18,19]. The distal anal canal is a 
delicate sensory organ that can distinguish 
between solids, gas and liquids. The neural 
supply to the anorectal region is both somatic 
and autonomic; branches of the pudendal 
nerve as well as direct branches from the 
sacral nerves contribute to the continence 





AI is a symptom, and its impact should be 
measured by the subjective perception of the 
patient [21]. At-risk patients require screening 
for symptoms, because patients are often 
reluctant to either report AI or seek help 
[22,23]. There are several validated 
questionnaires to evaluate symptoms and 
quality of life (QoL) changes. Symptom-
severity scales measure the frequency and 
severity of symptoms, while QoL scales 
evaluate the impact of symptoms on QoL. 
Table 2 lists commonly used questionnaires.
In addition to screening for symptoms and 
QoL changes, all patients require an in-depth 
medical, surgical and obstetric history. 
Information about bowel patterns, 
consistency, urgency, straining or 
constipation, sexual abuse or regular anal 
intercourse, medications, diet and fluid 
patterns should also be obtained. Physical 
examination includes an abdominal 
examination to exclude palpable masses. A 
pelvic examination should be performed, 
including neurological examination to assess 
sensory and motor function, including 
anocutaneous reflex, sacral reflexes and 
perineal sensation. Digital anorectal 
examinations evaluate sphincter 
abnormalities and strength (resting and 
squeeze tone), strength of the pubrectalis, and 
presence of fecal impaction, masses or 
haemorrhoids. Perineal inspection should 
include notation of scars, fissures or mucosal 
prolapse. The rest of the pelvis is evaluated 
for any associated pathology. Rectal 
examinations have proved as reliable as 
manometry for assessing rectal resting and 
squeeze tone [33]. Although there are 
standardized scales to evaluate pelvic floor 
exercise strength, there is no standard scale 
for evaluating rectal resting and squeeze tone 
[34,35]. Physical examination of the perianal 
tissues should include observation of fecal 
material on the perineum and separation of 
the anal sphincter, as assessed by the ‘dove 









PREVALENCE AND RISK FACTORS
 
Anal incontinence (AI) is defined as the 
involuntary loss of flatus, liquid or solid stool 
that causes a social or hygienic problem [1]. It 
is under-reported by patients and under-
recognized by providers, so the true 
prevalence is unknown. Published population-
based AI rates are 0.5–28% and AI is six to 
eight times more common in women than 
men [1,2]. In nursing-home populations, AI is 
endemic, and rates reach 47% [3]. Women 
with urinary incontinence (UI) and pelvic 
organ prolapse are at greater risk; up to a 
third also complain of AI symptoms [4]. 





2169 per patient per year, 





Anal continence is maintained by several 
mechanisms, including normal stool delivery 
and consistency, intact sensation and motor 
innervation, an intact anal sphincter complex, 
and a functioning puborectalis muscle. AI 
can result from damage to a part of the 
continence mechanism or from multiple 
insults over time. In young women, the most 
common cause of AI is childbirth; AI can occur 
after overt laceration of the anal sphincters, 
and from nerve or muscle damage during 
vaginal birth. Overt obstetric tears into the 
anal sphincter complex at the time of vaginal 
delivery occur in up to 6% of women [6–9]. 
Despite repair, 20–50% of women complain 
of involuntary loss of flatus or stool 
postpartum [10–13]. A third of obstetric 
sphincter injuries are detectable only with 
ultrasonography (US) or electromyography 
(EMG) of the anal sphincter complex and are 
not associated with overt perineal laceration 
 
R O G E R S  
 


















The use of diagnostic testing in the treatment 
of AI is limited by a lack of normative data, 
poor standardization of testing and reporting 
of results, and lack of information about the 
negative- and positive-predictive value of 
test results (for either diagnosis or clinical 
outcomes of therapeutic interventions). These 
deficiencies preclude rigid recommendations 
for the use of any or all of these methods, 
although they are often used. The utility of 
diagnostic tests, including endo-anal US, anal 
manometry, external anal sphincter EMG and 
defecating proctography, was evaluated in a 
study of 50 patients. Two experts made 
diagnoses based on medical history and 
physical examination, and then re-evaluated 
their diagnosis after diagnostic testing. 
Diagnoses were changed in 19% of cases, and 
management plans altered in 16%. Despite 
this, surgically treatable causes of AI were 
seldom missed [34].
US AND MRI
Current imaging tools to evaluate the anal 
sphincter complex include US (endoanal, 
endovaginal, translabial, and three-
dimensional), MRI and defecography. 
Endoanal US and MRI both have high soft-
tissue resolution capabilities in imaging pelvic 
floor anatomy, and can reliably detect anal 
sphincter disruptions. MRI gives excellent 
visualization of the anal sphincter complex, 
but is costly and its use is restricted to 
speciality centres [37]. Endoanal US is less 
costly, and findings correlate with anal 
manometry [38], EMG activity [39], MRI [40], 
and surgical findings [41,42]. Translabial 
imaging uses 8–10 MHz vaginal probes, which 
are found in most ultrasound diagnostic 
centres, but comparisons of translabial and 
‘gold standard’ endoanal US of the anal 
sphincter complex are scarce [43]. Recently, 
three-dimensional US was used to identify 
lesions both in the levator ani and anal 
sphincter complex with resolution similar to 
that of MRI; whether this will offer additional 
diagnostic capabilities to the practising 
clinician remains to be established [44,45].
DEFECOGRAPHY
Defecography provides dynamic evaluation of 
the pelvic floor providing both structural and 
functional information on the presence of 
enterocele, rectocele, cystocele, perineal 
descent, intussusseption and rectal prolapse. 
Dynamic MRI offers better images, but is 
again limited by cost and availability. 
Standardization both of testing and 
interpretation of defecography is not 
established, making its role in the diagnosis of 
AI undefined [46].
ANORECTAL MANOMETRY
Anorectal manometry provides functional 
information about anal resting and squeeze 
tone. A variety of instrumentation is available 
to measure anal pressures, including water-
filled perfusion catheters, water-filled or air-
filled balloons, sleeve catheters and pressure 
transducers. The most commonly used devices 
are water-perfused multichannel catheters 
with a radial array. The usefulness of testing 
is limited by the relative absence of 
standardized test protocols, normative data 
from healthy individuals or predictive value 




Summary of the causes of FI
 
Cause
Congenital Imperforate anus, rectal agenesis, cloacal defects (myelo)meningocele
Anatomical Obstetric injury, anorectal and visceral surgery (midline or lateral internal sphincterotomy, fistulectomy, colectomy, ureterosigmoidostomy, 
haemorroidectomy, hysterectomy), accidental injury such as pelvic fracture or anal impalement
Neurobiological Diabetes mellitus, multiple sclerosis, stroke, dementia, spina bifida, pudendal neuropathy due to nerve stretch injury (vaginal delivery, 
descending perineal syndrome, rectal prolapse, chronic straining at stool), degenerative changes of sphincter mechanism due to ageing, 
tabe dorsalis, central nervous system tumour, trauma, spinal cord injury or infection, Hirschsprung’s disease, Alzheimer’s disease, 
Parkinson’s disease, myotonic dystrophy, amyloidosis, multiple system atrophy (Shy–Drager syndrome), toxic alcohol neuropathy, 
myasthenia gravis
Functional Psychiatric disorders, retarded or interrupted toilet training, malabsorption, inflammatory bowel disease, radiation proctitis, hypersecretory 
tumours, rectal intussusception, fecal impaction, physical disabilities, encopresis, laxative abuse, anal fistula, irritable bowel syndrome, 
post-cholecystectomy and infectious diarrhoea, drug side-effects
 








Symptom severity and QoL scales
 
Scale (abbreviation) Type Number questions
Wexner FI scale (FIS) [24] Symptom severity 5
American Medical Systems score (AMS) [25] Symptom severity 5
Pescatori score [26] Symptom severity 3
Vaizey scale [27] Symptom severity 7
FI severity index (FISI) [28] Symptom severity 5
Colo-Rectal-Anal Impact Questionnaire (CRAIQ) [29] QoL Short form 7; Long
form 31
FI QoL scale (FIQOL) [30] QoL 29
Manchester Health Questionnaire (MHQ) [31] Symptom severity, QoL 31
Modified Manchester Health Questionnaire (MMHQ)
[32]
Symptom severity, QoL 38
 






2 0 0 6  T H E  A U T H O R S








provide supplementary functional 
information to the evaluation of anatomy 
provided by US.
NEURODIAGNOSTIC STUDIES
EMG data can be obtained from either surface 
leads or needles. Surface EMG can be useful 
for evaluating patients with impaired squeeze 
tone, to differentiate between muscle damage 
and nerve damage. Needle EMG or mapping 
of anal sphincter defects is no longer 
recommended for the routine clinical 
evaluation, and has been replaced by US and 
MRI [47,48]. Although commonly used, 
pudendal nerve latency provides information 
only about the activity of the fastest nerve 
fibres and does not provide reliable 
information about nerve damage. Despite 
prolonged latencies, patients undergoing 
anterior sphincteroplasty had a significant 
improvement in continence with minimum 
morbidity, underlining its limited use in 
determining who should have surgical 




Although AI is difficult to cure, most patients 
note an improvement from medical or 
surgical interventions. All patients should 
have a trial of medical management before 
surgical management because of sub-optimal 
long-term success rates for the surgical 
correction of AI. A frank discussion about 
expectations for continence after either 
surgical or medical management is essential 
for patient counselling.
NON-SURGICAL MANAGEMENT
Non-surgical management options for AI 
include dietary and fluid manipulation, 
medications, enemas, behavioural and 
physical therapy, biofeedback, and use of 
plugs and pads. Bowel regimens, including 
regular toileting, the use of enemas, and 
dietary and fluid manipulations, might not 
cure AI, but might enable the patient to 
resume a more active lifestyle.
 
Dietary and fluid management
 
Increasing dietary fibre with diet changes, or 
bulking agents or fibre supplements such as 
methyl cellulose or psyllium, helps to increase 
stool size. A larger, better formed stool might 
improve rectal sensation and emptying. 
However, in some patients increasing fibre 
can worsen AI. These patients might be better 
treated by constipating agents and a bowel 




Pharmacotherapy for AI can be divided into 
three groups. Constipating agents, including 
loperamide (Imodium), diphenoxylate 
hydrochloride and atropine sulphate 
(Lomotil), are most beneficial to women 
with AI related to watery or loose stools. 
Constipating agents reduce urgency, 
incontinence episodes, and pad use. Side-
effects include constipation, abdominal pain, 
diarrhoea, headache, and nausea. No data 
support using constipating agents for 
patients with normal stool consistency [50].
Drugs that enhance anal sphincter tone 
include phenylepinephrine gel, sodium 
valproate and loperamide. These help most in 
cases of AI with normal anal sphincter 
function. Side-effects include a localized 
dermatitis with phenylepinephrine gel, and 
abdominal pain and nausea with sodium 
valproate. Laxatives are beneficial in cases of 
AI associated with constipation and fecal 
impaction. Hormone replacement therapy 
might be beneficial for postmenopausal 
women with AI. A small prospective 
observational study of 20 women found that 
AI symptoms improved in 65% of cases, and 
25% became asymptomatic after 6 months of 
use. Further investigation is needed to 
confirm these results [51].
 
Physical therapy and biofeedback
 
Pelvic floor muscle training is a well 
established treatment for UI [52]. Because the 
striated anal sphincter in under voluntary 
control, it is theoretically amenable to the 
same re-education and strengthening 
techniques used for treating UI [53]. 
Physiotherapy with or without biofeedback is 
often prescribed for treating AI and, because 
they are commonly done together, separating 
their effects is difficult. Biofeedback involves 
mechanical or electrical devices that provide 
sensory feedback to the patient about the 
efficacy of voluntary control of continence; it 
can be used to ‘retrain’ the rectum to increase 
sensitivity to fecal material boluses and can 
enhance the ability to appreciate rectal filling 
as well as increasing sphincter squeeze tone. 
Patients with voluntary sphincter control and 
normal rectal sensation benefit more than 
those without [54]. In a prospective cohort 
study of 266 patients, physical and 
biofeedback therapy interventions were 
shown to improve squeeze pressure, urge 
sensation and maximum tolerable volume in 
the short term [55]. Another prospective 
cohort study evaluated 105 patients (12 
males) who had not responded to dietary 
manipulation, medications and timed 
toileting, and were then enrolled in a 
biofeedback programme. Patients had three to 
eight sessions initially, and reinforcement 
sessions at 3, 6 and 12 months. Sessions 
included pelvic floor muscle-strengthening 
exercises with biofeedback training using 
manometry; a mean of 7.8 sessions/patient 
were required. Resting and squeeze anal 
sphincter pressures increased, as well as the 
squeeze duration. Rectal sensory perception 
improved, as did the threshold for a desire to 
defecate, and the ability to retain saline 
infusions [56]. Randomized data evaluating 
biofeedback have provided mixed outcomes. 
Advice and education improved continence, 
QoL, psychological well-being, and anal 
sphincter function, compared to pelvic floor 
exercises or biofeedback. The benefits of this 
simple intervention were maintained at 1 year 
after finishing treatment [57]. Another 
randomized trial compared pelvic floor 
exercises with biofeedback from digital 
examination, to biofeedback with manometry 
or US, and found no differences among the 
three interventions; all showed a significant 
improvement in symptom severity in patients 
with mild-to-moderate fecal incontinence (FI, 





Anal electrical stimulation for the treatment 
of AI was first described over 40 years ago. 
Surface electrodes, intra-anal or intravaginal 
plugs are used to deliver high frequency 
electrical stimulation. It is not known whether 
the beneficial effects are secondary to muscle 
strengthening, rectal sensitization, or some 
general effect [59]. Most protocols 
recommend high-frequency stimulation at 
50 Hz for 15–20 min twice daily. Electrical 
stimulation is often used in conjunction with 
physiotherapy and biofeedback, making 
separation of the effects of these 
interventions difficult.
The efficacy of electrical stimulation therapy 
was studied in three randomized trials. Two 
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trials evaluated its effect on postpartum FI; 
the first randomized 40 women to anal 
biofeedback and exercises with electrical 
stimulation, or vaginal biofeedback and 
exercises with no electrical stimulation. The 
authors reported that women with electrical 
stimulation had a greater improvement in 
continence status than the group with no 
electrical stimulation; however, group 
assignment varied both in the delivery of 
electrical stimulation and the route (endo-
anal vs endovaginal) of biofeedback [60]. A 
second trial randomized 60 postpartum 
women to intra-anal EMG biofeedback 
physiotherapy with or with no electrical 
stimulation. In both groups there was a 
significant improvement in FI and QoL scores, 
but no added benefit of electrical stimulation 
[61]. A third trial randomly assigned 90 
patients with FI to two groups, one with daily 
‘therapeutic’ anal electrical stimulation of 
35 Hz, and the other to ‘sham’ stimulation 
with 1 Hz. There was no statistically 
significant difference between the groups in 
the improvement in bowel control, suggesting 
that the mechanism of action of electrical 
stimulation might be secondary to improved 
sensitization rather than muscle 
strengthening [59].
 
Sacral nerve stimulation (SNS)
 
SNS as a treatment option for FI was first 
described in 1995 [62]. Motor output from the 
sacral and pudendal nerves, and modulation 
of both local spinal reflex arcs and autonomic 
supply to the rectum, pelvic floor and the 
spinal tracts to the higher centres in the brain 
are provided by electrodes implanted in the 
sacral foramen [20]. Because efficacy was 
shown in divergent populations, the selection 
of patients for placement is pragmatic [20]. 
Permanent implantation is based on the 
functional results achieved after a temporary 
testing period with peripheral nerve 
stimulation [63]. Patients who respond during 
the test period are then permanently 
implanted with pulse generators.
The efficacy of SNS was shown not to be due 
to a placebo effect in a double-blind crossover 
study of 34 patients [64]. Most series 
evaluating the treatment of AI with SNS are 
small (5–30 patients) with a follow-up of 
4.5–32 months. Most studies showed a 
significant improvement, as measured by 
incontinent episodes, incontinence scores, 
or both, but there have been no long-term 
multicentre trials [20]. A recent prospective 
study followed 46 patients (four males) from 
several centres in the UK for a median of 
12 months; 41% achieved full continence 
to liquid and solid stool, and a subset 
followed for 6 years after implantation have 
maintained their continence [65]. Potential 
complications associated with this treatment 
are low, with an overall removal rate of 4% 





Anal plugs are specially developed devices for 
containing FI. They were first used for patients 
with FI resulting from major neurological 
problems. Available data suggest that plugs 
are not tolerated well, and in many trials, 
many patients stopped using them. 
Polyurethane plugs performed better than 
polyvinyl-alcohol plugs in one randomized 
trial [68]. Plugs can be used as an alternative 
to other forms of management or as an 
adjuvant treatment for patients with FI [69].
SURGICAL MANAGEMENT
The surgical management of AI includes 
sphincteroplasty, the placement of 
artificial neosphincters, implantation of 
sacroneuromodulation generators, and 
newer techniques of bulking agents or 
radiofrequency ablation. Unfortunately, post-
anal repair or posterior levatorplasty has not 
been shown to be effective for FI in most 




The mainstay of surgical intervention for AI is 
anterior sphincteroplasty for patients with 
anterior sphincter defects. Two methods of 
external anal sphincter repair are commonly 
used; the traditional ‘end-to-end’ technique, 
or an overlapping technique. Parks [70] first 
introduced the overlapping repair in 1971 
because of what was thought to be 
unsatisfactory success rates with end-to-end 
repairs. Initial results with overlapping 
sphincteroplasty were good, with 60–82% of 
patients reporting symptom improvement 
with short-term follow-up [1,34]. More 
recently, five papers reported less promising 
longer-term results with mean follow-ups of 
3–10 years. After overlapping repair, cure 
rates of 0–28% were reported [71–75] 
(Table 3).
Anorectal physiological testing or clinical 
features other than patient age in one study 
[71], and the presence of a persistent internal 
anal sphincter defects in another [74], did not 
predict long-term outcomes. Continence to 
flatus was rare, suggesting that surgical 
intervention for flatal incontinence might 
have very limited efficacy.
Three randomized trials compared the two 
repair methods. Two trials randomized 
postpartum women to overlapping or end-to-
end primary repair of obstetric lacerations. 
In a trial of 112 women, anatomical and 
functional success rates were equally poor 




60% of patients had evidence of sphincter 
separation on postpartum US, and over half 
complained of AI symptoms [10]. A more 
recent randomized trial had similar results, 
with 41 women randomized, 23 to an end-to-
end and 18 to an overlapping repair. Objective 
US findings were promising; 85% of patients 
had intact sphincters, with no difference 
between the groups. Although the external 
sphincters appeared intact, 42% of women 
still complained of anorectal symptoms, and 
there were no differences between the groups 
[76]. These trials are in contradistinction to an 
obstetric cohort study with historic controls, 
which found that AI symptoms decreased 
from 41% to 8% with overlapping repair, and 
high anatomical success (85%) measured by 
an intact sphincter complex on US [14]. One 
randomized trial that compared overlapping 
to end-to-end repair, in 23 patients 
undergoing sphincter repair remote from 
delivery, reported that the patient-rated 
success of 75% was the same in both groups 
at a mean of 18 months of follow-up; the 
authors concluded that there was no 
difference in success rates of the two 
methods [77].
Variation in surgical technique was studied in 
one randomized trial, which found that 
opening incisions close to the posterior 
Fourchette had fewer wound complications 
than incisions made in the line of the vaginal 
mucocutaneous junction [78]. Repair of the 
internal anal sphincter is controversial, but 
one author reported increased continence 
rates in women with an intact internal anal 
sphincter after repair of obstetric third- or 
fourth-degree lacerations [79]. The type of 
suture used for anal sphincter repair has not 
been studied in randomized trials. However, 
polyglycolic acid and catgut were compared 
for repair of obstetric laceration repair and 
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episiotomy in large randomized trials; 
polyglycolic acid was associated with 
decreased pain and analgesia use, as well 
as decreased rates of wound separation 
[80–82].
Peri-operative care is poorly studied. 
Extensive bowel preparations that include 
both mechanical and antibiotic treatments, 
accompanied by a restricted diet for 1–3 days 
before surgery, are commonly used. Six 
randomized trials evaluated the role of 
mechanical bowel preparations in patients 
undergoing bowel anastomosis and found 
no difference in wound infection rates or 
other variables measured [83]. One dose 
of broad-spectrum i.v. antibiotic administered 
during repair is commonly used, and some 
continue oral antibiotics for 1 week after 
repair [10,14]. Dietary restrictions are also 
commonly used after surgery, although 
one randomized controlled trial of 54 
patients who had anorectal reconstructive 
surgery found that women randomized to 
a regular diet after surgery were less likely 
to have fecal impaction, and had their 
first postoperative bowel movement 
sooner than women on a clear diet and 
oral constipating agents. There were no 
differences in septic or urological 
complications [84].
Women with anal sphincter defects and 
abnormal neurological testing (e.g. delayed 
pudendal nerve motor latencies) have 
lower rates of continence after surgery 
than women with normal testing [1]. 
Despite poor objective outcomes with 
sphincteroplasty, many patients are 
satisfied with the improvement in 
function despite continued AI, and 
would choose to have the surgery 
again [1,72]. Detailed counselling and 
goal-setting by both patient and providers 





Neosphincters encircle the anal canal and act 
as a substitute for the anal sphincter, and can 
be of biological or artificial origin. Their use 
has been limited by significant morbidity, and 
serious complications occur in more than half 
of patients.
Gracilis muscle transposition is the most 
common technique for creating a biological 
neosphincter. Initial results were poor, which 
led to the addition of the implantation of a 
device to electrically stimulate the transposed 
gracilis muscle. The intention of this 
modification was to transform fast-twitch 
fatigable anal sphincter muscle fibres to slow-
twitch fatigue-resistant fibres [85–87]. Using 
this technique, a prospective multicentre trial 
with a mean follow-up of 23 months reported 
symptom improvement in 74% of patients, 
adverse events in 74%, and a re-operation 
rate of 40% for complications [87]. Another 
more recent prospective study of 28 patients 
with congenital anorectal malformations 
reported satisfactory continence in 35% of 
them, and a complication rate of 53%, with 
the most serious being infection [88].
Artificial anal sphincters are composed of a 
cuff that encircles the anal canal below the 
plane of the levator ani muscle. The cuff is 
connected to an intraperitoneal reservoir 
operated by a control implanted in the labia or 
scrotum. Early data reported symptomatic 
improvement in half of patients [89]. 
Unfortunately, this procedure is associated 
with significant morbidity, including infection, 
wound breakdown, cuff or pump erosion, 
fecal impaction, and mechanical failure 
[90]. A recent review of reports on the 
effectiveness and safety of artificial 
sphincters concluded that the procedure 





Since first reported in 1993 [92], several 
agents have been used to treat cases of 
FI with submucosal injections of PTFE, 
autologous fat, glutaraldehyde cross-linked 
collagen, or carbon-coated zirconium oxide 
beads. Injections are either trans-sphincteric 
[93], or proctoscoptically guided through 
the rectal mucosa above the dentate line 
[94]. A recent randomized trial compared 




Long-term results after overlapping sphincteroplasty
 





 [71] 46/55 (84) 77 months (60–96) 0% continent







 [72] 74/86 (86) 40 months 28% continent












 [74] 135/191 (71) 10 years (7–16) 6% continent







 [75] 56/65 (86) 80 months (26–154) 27% continent
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Treatment algorithm for management of AI.
+ Anterior defect − Anterior defect
Anal Incontinence
History and physical 
Assess Symptom 
Severity and Quality 
of Life 
Normal Stool Diarrhea Constipation 
Fecal impaction 
Rectovaginal fistula
Rectal prolapse  
Surgery Stool examination-rule 









↑ or ↓ Dietary fiber
↑ Fluid intake 






















Assess anatomy/function sphincter complex
Physical exam
± Ultrasound  ± Manometry         
± Defacography     ± Neurodiagnostic studies  
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with and with no US guidance and showed 
more improvement in continence in the 
US-guided group [95]. More data are needed 






energy is delivered to the anorectal junction 
after local block at several sites. Evaluation of 
the efficacy and safety of this procedure 
showed a significant improvement in AI 
symptoms in 60% of patients and a 
complication rate of 4% [96], with benefits 
potentially extending to 2 years after ablation 
[97]. Similar techniques for the treatment of 
UI had poor long-term success rates, and 





A diverting procedure is the last choice for 
patients who fail other treatments for their AI, 
and whose AI has a major impact on their QoL. 
These patients should be evaluated carefully 
before considering this procedure, including 
psychiatric counselling. Most patients report 
an improvement in their QoL after colostomy, 
despite the difficulties that they face in caring 
for the stoma [98].
In conclusion, the evaluation and treatment 
of patients with AI is complex. A proposed 
strategy for management of these patients is 
summarized in Fig. 1. Because of poor long 
term surgical outcomes non-surgical therapy 
should be pursued in the majority of patients, 
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